Today's Updates

Rheumatology in 2025: Year in Review Victoria Johnson
Published Date: 15 Jan 2026

The rheumatology year in review highlights FDA approvals and pivotal data readouts.

Read More
Nipocalimab Reduces SLE Disease Activity, Meeting JASMINE Study End Point Victoria Johnson
Published Date: 15 Jan 2026

Johnson & Johnson plans to initiate a phase 3 study based off the positive data.

Read More
Secondary Analysis Finds Oveporexton Improves Cognitive Function in Adults With Narcolepsy Type 1 Louie Pasculli
Published Date: 15 Jan 2026

Treatment with the orexin-receptor 2 agonist oveporexton was associated with improvements in attention, memory, and executive function in adults with narcolepsy type 1.

Read More
Phase 3 Data Readout of EMPEROR Study to Come Earlier, With FDA Submission Expected to Follow Marco Meglio
Published Date: 15 Jan 2026

Those from the clinical community may expect to hear data from the registrational trial assessing zorevunersen in Dravet syndrome by mid-2027.

Read More
sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis Marco Meglio
Published Date: 15 Jan 2026

The FDA is expected to have a decision on efgartigimod as potentially the first approved therapy for seronegative myasthenia gravis by May 10, 2026.

Read More
Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101
Published Date: 15 Jan 2026

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Read More
Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression
Published Date: 15 Jan 2026

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Read More
FDA Extends Sparsentan (Filspari) sNDA Review for Focal Segmental Glomerulosclerosis
Published Date: 15 Jan 2026

FDA Extends Sparsentan (Filspari) sNDA Review for Focal Segmental Glomerulosclerosis

Read More
Elevated BMI and Physical Inactivity Drive Rising Global Hypertension-CKD Burden
Published Date: 15 Jan 2026

Elevated BMI and Physical Inactivity Drive Rising Global Hypertension-CKD Burden

Read More
FDA Approves Tradipitant (NEREUS) for the Prevention of Vomiting Induced by Motion
Published Date: 15 Jan 2026

FDA Approves Tradipitant (NEREUS) for the Prevention of Vomiting Induced by Motion

Read More
Upadacitinib Outperforms 4 JAK Inhibitors in Atopic Dermatitis Meta-Analysis
Published Date: 15 Jan 2026

Upadacitinib Outperforms 4 JAK Inhibitors in Atopic Dermatitis Meta-Analysis

Read More
Pediatric Eczema Severity, Quality of Life Not Influenced by Phototype, Ethnicity
Published Date: 15 Jan 2026

Pediatric Eczema Severity, Quality of Life Not Influenced by Phototype, Ethnicity

Read More

Latest News


Latest News

News All Time


Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

2.

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

3.

Alone for 500 Days, but Never Lonely: The Introvert's Dream.

4.

Study indicates that exercise can help colon cancer survivors live as long as matched individuals

5.

Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors



© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot